BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16336503)

  • 1. Nociceptin/orphanin FQ-induced delay in gastric emptying: role of central corticotropin-releasing factor and glucocorticoid receptors.
    Broccardo M; Scaccianoce S; Del Bianco P; Agostini S; Petrella C; Improta G
    Neurogastroenterol Motil; 2005 Dec; 17(6):871-7. PubMed ID: 16336503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypothalamus-pituitary-adrenal axis does not influence the protective effects of nociceptin/orphanin FQ on the rat gastric mucosa.
    Grandi D; Solenghi E; Guerrini R; Broccardo M; Agostini S; Petrella C; Scaccianoce S; Improta G; Morini G
    Regul Pept; 2009 Apr; 154(1-3):32-8. PubMed ID: 19046996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
    Leggett JD; Harbuz MS; Jessop DS; Fulford AJ
    Neuroscience; 2006 Sep; 141(4):2051-7. PubMed ID: 16784820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal effects of intracerebroventricularly injected nociceptin/orphaninFQ in rats.
    Broccardo M; Guerrini R; Petrella C; Improta G
    Peptides; 2004 Jun; 25(6):1013-20. PubMed ID: 15203249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ.
    Ciccocioppo R; Fedeli A; Economidou D; Policani F; Weiss F; Massi M
    J Neurosci; 2003 Oct; 23(28):9445-51. PubMed ID: 14561874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional antagonism between nociceptin/orphanin FQ and corticotropin-releasing factor in rat anxiety-related behaviors: involvement of the serotonergic system.
    Filaferro M; Ruggieri V; Novi C; Calò G; Cifani C; Micioni Di Bonaventura MV; Sandrini M; Vitale G
    Neuropeptides; 2014 Aug; 48(4):189-97. PubMed ID: 24894718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orphanin FQ-induced hyperphagia is mediated by corticosterone and central glucocorticoid receptors.
    Nicholson JR; Akil H; Watson SJ
    Neuroscience; 2002; 115(2):637-43. PubMed ID: 12421628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nociceptin/orphanin FQ antagonist UFP-101 differentially modulates the glucocorticoid response to restraint stress in rats during the peak and nadir phases of the hypothalamo-pituitary-adrenal axis circadian rhythm.
    Leggett JD; Jessop DS; Fulford AJ
    Neuroscience; 2007 Jul; 147(3):757-64. PubMed ID: 17574767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gastric effects of UFP-112, a new nociceptin/orphanin receptor agonist, in physiological and pathological conditions.
    Broccardo M; Guerrini R; Morini G; Polidori C; Agostini S; Petrella C; Improta G
    Peptides; 2007 Oct; 28(10):1974-81. PubMed ID: 17765363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis.
    Lowery EG; Spanos M; Navarro M; Lyons AM; Hodge CW; Thiele TE
    Neuropsychopharmacology; 2010 May; 35(6):1241-52. PubMed ID: 20130533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions.
    Broccardo M; Linari G; Guerrini R; Agostini S; Petrella C; Improta G
    Peptides; 2005 Sep; 26(9):1590-7. PubMed ID: 16112397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 1 beta inhibits gastric emptying in rats: mediation through prostaglandin and corticotropin-releasing factor.
    Sütö G; Király A; Taché Y
    Gastroenterology; 1994 Jun; 106(6):1568-75. PubMed ID: 8194703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin-releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis.
    Rodi D; Zucchini S; Simonato M; Cifani C; Massi M; Polidori C
    Psychopharmacology (Berl); 2008 Mar; 196(4):523-31. PubMed ID: 17989958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of brain nicotinic acetylcholine receptor in centrally administered corticotropin-releasing factor-induced elevation of plasma corticosterone in rats.
    Okada S; Yamaguchi-Shima N; Shimizu T; Arai J; Lianyi L; Wakiguchi H; Yokotani K
    Eur J Pharmacol; 2008 Jun; 587(1-3):322-9. PubMed ID: 18423439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nociceptin/orphanin FQ acts as a functional antagonist of corticotropin-releasing factor to inhibit its anorectic effect.
    Ciccocioppo R; Cippitelli A; Economidou D; Fedeli A; Massi M
    Physiol Behav; 2004 Aug; 82(1):63-8. PubMed ID: 15234592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central CRF inhibits gastric emptying of a nutrient solid meal in rats: the role of CRF2 receptors.
    Martinez V; Barquist E; Rivier J; Taché Y
    Am J Physiol; 1998 May; 274(5):G965-70. PubMed ID: 9612279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abdominal surgery-induced delayed gastric emptying in rats: role of CRF and sensory neurons.
    Barquist E; Zinner M; Rivier J; Taché Y
    Am J Physiol; 1992 Apr; 262(4 Pt 1):G616-20. PubMed ID: 1566844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the nociceptin/orphanin FQ system is unable to reverse CRF2 receptor mediated anorexia in the rat.
    Fedeli A; Policani F; Ubaldi M; Cippitelli A; Massi M; Ciccocioppo R
    Peptides; 2006 Dec; 27(12):3284-91. PubMed ID: 17050037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nociceptin/orphanin FQ regulates neuroendocrine function of the limbic-hypothalamic-pituitary-adrenal axis.
    Devine DP; Watson SJ; Akil H
    Neuroscience; 2001; 102(3):541-53. PubMed ID: 11226692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nociceptin/orphanin FQ and related peptides reduce the increase in plasma corticosterone elicited in mice by an intracerebroventricular injection.
    Le Cudennec C; Naudin B; Do Rego JC; Costentin J
    Life Sci; 2002 Nov; 72(2):163-71. PubMed ID: 12417250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.